Senate Bill S. 3315 Would Convert MFA and Encryption into HIPAA Statutory Requirements

Senate passes mandatory healthcare cybersecurity controls

The U.S. Senate passed the Health Care Cybersecurity and Resiliency Act (S. 3315) by unanimous consent on September 30, 2026. The bill is not yet law—the House must still act—but it would convert currently recommended HIPAA controls into statutory requirements. If enacted, covered entities and business associates would have 36 months to implement multifactor authentication, encryption of electronic protected health information, continuous monitoring, penetration testing, and risk-based cybersecurity practices aligned with NIST and CISA frameworks.

The bill would require HHS to update HIPAA-related rules to mandate these controls. It would also establish annual sector cybersecurity reporting covering significant threats, major incidents, security posture, HHS actions, and recommended improvements. Authorized grants would support rural and under-resourced providers, though no funding amount has been specified.

The 36-month implementation window creates a credible timeline for procurement and deployment, but the House has not passed the measure. HHS's separate HIPAA Security Rule update has been delayed until at least July 2027, creating uncertainty over whether buyers should purchase against proposed federal controls now or wait for final language.

What this means for enterprise healthcare budgets

The bill creates budget pressure in five areas: MFA for systems containing ePHI, encryption at rest and in transit, network monitoring, recurring penetration testing, and third-party-risk evidence collection. Business associates—including healthcare-focused managed security providers—would face downstream requirements if the bill becomes law.

Vendors that combine HIPAA evidence with technical enforcement will gain competitive advantage. Risk-management platforms, managed security providers, identity vendors, vulnerability-management products, and healthcare-specific third-party-risk tools will compete for the compliance spend. Products that produce exportable evidence and maintain remediation ownership over time will outperform generic checklist-based HIPAA consultants and point-in-time assessment tools.

Buyers should avoid treating S. 3315 as an immediate mandate. The most defensible approach is to budget toward MFA coverage, encryption, CISA/KEV-driven vulnerability management, recurring testing, and auditable remediation workflows while preserving contract flexibility until Congress and HHS finalize the requirements.

CISA findings are becoming compliance evidence

A healthcare compliance update published October 7–8 recommends incorporating CISA Cyber Hygiene vulnerability-scanning results, Known Exploited Vulnerabilities catalog findings, patch records, remediation dates, vendor inventories, and business-associate agreements into HIPAA risk analyses. CISA's Cyber Hygiene service scans internet-facing systems and delivers recurring email reports; organizations are advised to compare findings with CISA's KEV catalog.

The recommended evidence set includes scan results, patch records, documented remediation dates, workforce-training attestations, and current business associate agreements for every vendor handling ePHI. This strengthens the position of vulnerability-management, attack-surface-management, third-party-risk, and compliance-evidence platforms that can ingest CISA findings and map them to HIPAA controls.

Procurement requirements should now include KEV prioritization, internet-facing asset discovery, patch-status tracking, business associate agreement inventory, and audit-ready records. The update does not provide adoption figures, pricing, breach reduction results, or measured performance benchmarks, so this is a compliance-practice development rather than a quantified market shift.

Vendor activity remains thin on evidence

Censinet announced on October 8 that its Censinet RiskOps platform won an "Overall Risk Management Solution of the Year" award. The product is positioned as an AI-native healthcare risk-intelligence platform competing with healthcare third-party-risk platforms, enterprise GRC suites, managed security providers, and specialized HIPAA compliance tools. The announcement supplies no customer count, contract value, pricing, risk-reduction benchmark, assessment-volume figure, or independently validated performance result.

What to watch

Track House action on S. 3315 and HHS's July 2027 HIPAA Security Rule update timeline. If both advance, enterprise healthcare organizations will face a defined compliance window starting in 2028 or 2029. Budget planning should assume mandatory MFA, encryption, continuous monitoring, and penetration testing become baseline requirements, not optional best practices.

Contract terms should preserve flexibility until final language is published. Avoid multi-year commitments to single-point controls that may not align with the final regulatory framework. Favor platforms that produce exportable evidence, integrate CISA findings, track remediation ownership, and support business associate oversight.